EU pharmacovigilance regulations require each marketing authorisation holder, national competent authority and EMA to operate a pharmacovigilance system. Grove provides a network of local QPPV (Qualified Person for Pharmacovigilance) experts in Poland, Hungary, Czech Republic, Slovakia, Romania, Bulgaria, Slovenia, Croatia, Latvia, Estonia and Lithuania as a solution for pharmacovigilance issues at a national level. These highly skilled and continuously trained professionals provide a full range of pharmacovigilance and medical device vigilance services to enable Grove clients to maintain compliance with EU drug safety and pharmacovigilance requirements.
Our local pharmacovigilance resources are available on a 24-hour/7 day per week basis to receive notices for any safety information, safety issue or signal for your products. The local contact person reports to the client’s European qualified person responsible for pharmacovigilance activities, in accordance with the laws and regulations applicable in a country.
Grove’s local QPPV personnel take the responsibility for the collection and accurate documentation of all safety information received on national level and assists with follow-up. Safety information is forwarded to the client within the timeframes and format specified in individual Safety and Medical Information Agreements. Furthermore, we undertake regular monitoring of local publications and medical scientific literature and notify clients of published safety information regarding the products.Moreover, our pharmacovigilance activities at a national level cover the following areas:
Most importantly, pharmacovigilance services at a national level ensure patient safety, fulfilment of all local and national regulatory requirements and general compliance with current international guidelines for Good Pharmacovigilance Practices.